MarketPulse

drug safety concerns

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Llp

Soleno Therapeutics Faces Class Action Over Alleged Safety Misrepresentations

Robbins LLP files class action against $SLNO over safety concerns regarding its Prader-Willi syndrome drug, following critical exposé and patient death disclosure.
SLNOclass action lawsuitstock decline
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Soleno's VYKAT XR Faces Legal Storm as Safety Concerns Tank Stock 40%

Soleno Therapeutics faces securities lawsuit after hyperphagia drug VYKAT XR launch falters amid safety concerns, driving shares down 40% since August short seller report.
SLNOstock declinesecurities class action